A Drug-Interaction Study of Necitumumab (IMC-11F8) in Combination With Gemcitabine-Cisplatin
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Malignant Solid Tumor
Interventions: BIOLOGICAL: Necitumumab|DRUG: Gemcitabine|DRUG: Cisplatin
Sponsor: Eli Lilly and Company